KPIs & Operating Metrics(New)

Sabra Health Care REIT (SBRA) EPS (Weighted Average and Diluted) (2016 - 2025)

Sabra Health Care REIT (SBRA) has 15 years of EPS (Weighted Average and Diluted) data on record, last reported at $0.11 in Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) fell 45.0% year-over-year to $0.11; the TTM value through Dec 2025 reached $0.64, up 18.52%, while the annual FY2025 figure was $0.64, 18.52% up from the prior year.
  • EPS (Weighted Average and Diluted) reached $0.11 in Q4 2025 per SBRA's latest filing, up from $0.09 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.27 in Q2 2025 and bottomed at -$0.61 in Q2 2021.
  • Average EPS (Weighted Average and Diluted) over 5 years is $0.05, with a median of $0.1 recorded in 2024.
  • Peak YoY movement for EPS (Weighted Average and Diluted): tumbled 535.71% in 2021, then surged 375.0% in 2024.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.11 in 2021, then skyrocketed by 163.64% to $0.07 in 2022, then rose by 14.29% to $0.08 in 2023, then skyrocketed by 150.0% to $0.2 in 2024, then tumbled by 45.0% to $0.11 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Weighted Average and Diluted) were $0.11 in Q4 2025, $0.09 in Q3 2025, and $0.27 in Q2 2025.